Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

Revolution Medicines (RVMD) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 159.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.03 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 2.12 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn - 381.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381.98 Mn
Mar 31, 2026 383.89 Mn
Dec 31, 2025 373.29 Mn
Sep 30, 2025 487.24 Mn
Jun 30, 2025 571.02 Mn
Mar 31, 2025 497.35 Mn
Dec 31, 2024 303.53 Mn
Sep 30, 2024 346.93 Mn
Jun 30, 2024 485.20 Mn
Mar 31, 2024 456.88 Mn
Dec 31, 2023 141.52 Mn
Sep 30, 2023 249.93 Mn
Jun 30, 2023 133.75 Mn
Mar 31, 2023 198.85 Mn
Dec 31, 2022 156.11 Mn
Sep 30, 2022 93.05 Mn
Jun 30, 2022 192.58 Mn
Mar 31, 2022 157.73 Mn
Dec 31, 2021 120.53 Mn
Sep 30, 2021 138.53 Mn
API Access

Revolution Medicines Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RVMD&period=max&api_key=YOUR_API_KEY